Internet-based interdisciplinary therapeutic group (Grupo Interdisciplinar Online, GIO) for perinatal anxiety and depression-a randomized pilot study during COVID-19.

Early interventions may promote reductions in mothers' anxiety-depression (AD) symptoms and improvements in their offspring. This longitudinal randomized research was conducted to assess the effects of interdisciplinary online therapeutic groups (GIO) in at-risk mothers and babies during the COVID-19 pandemic in a disadvantaged neighborhood in Barcelona (Spain). A total of 135 babies were born from March 2020 to June 2021 in a primary healthcare center of Barcelona (Spain). Pregnant woman and new mothers were screened for AD symptomatology through EPDS and STAI questionnaires. Seventy-two of them met high-risk criteria for AD and were included in the study. They were randomly assigned into the two groups of the study: 40 participants were assigned to GIO, the therapeutic group (TG), while 32 of them were assigned to the control group (CG) and received treatment as usual. The course of the mothers' symptomatology was assessed, as well as the baby's development at 6 months old in a blind pediatric follow-up. No differences were found in AD between both groups before the intervention. However, we obtained a significant decrease in AD symptomatology (EPDS p < .001; STAI state p = .015 and STAI trait p < .001at 6 months of life) after the intervention in the TG compared to the CG. Pediatric follow-up at 6 months demonstrated significant differences between groups in babies' development assessment (manipulation p = .003; language p < .001; sociability p < .001). The GIO helped to ensure healthy development of the baby and reduction of the mothers' depressive-anxiety symptomatology.

[The Geneva prenatal interview: to prepare to parenthood and detect emotional troubles]. / Entretien prénatal genevois: préparer à la parentalité et dépister les troubles émotionnels.

Emotional disorders are common during the perinatal period and can have negative consequences on the woman's physical and mental health, as well as on the mother-child relationship. Screening for these difficulties is complicated because of a lack of knowledge and a lack of simple and validated tools that can be used on a large scale. A Geneva multidisciplinary team has developed a prenatal interview model, provided by specifically trained midwives. It aims to sensitize pregnant women, offer them a personalized space of listening, detect psychological weakness, develop resources and orient patients in need to specific care centers. This paper describes this interview and its main implications for clinical practice.

[Use of an easily administered instrument to detect the risk of postpartum depression]. / Le DAD-P: un outil simple pour le dépistage anténatal du futur risque de dépression du postpartum.

The detection of postpartum depression (PPD) is an important public health issue because of its negative consequences on both the mother's and the infant's health. Up to now, one of the major difficulties is to find a simple and valid instrument able to detect women at risk to develop PPD already during pregnancy. The present article describes a short, simple questionnaire that was developed in Geneva, the Questionnaire de Dépistage Anténatal du risque de Dépression du Postpartum (DAD-P), previously named le Questionnaire de Genève. The authors propose a preventive strategy and follow-up that can be used by any health professional working with pregnant women.

[Psychiatry]. / Psychiatrie.

The main innovation of the year 2004 was the introduction of a new, second-generation antipsychotic drug with a new mechanism of action (partial dopamine agonist), encouraging first clinical results, and an advantageous clinical tolerance profile. Additionally, three new galenic forms are presented: an oral, extended-release form of methylphenidate that could be useful in the treatment of attention-deficit/hyperactivity disorders; an intramuscular depot form of a second-generation antipsychotic drug (risperidone) with the advantage of improving adherence; and an intramuscular form of a second generation antipsychotic (olanzapine) that is valuable in emergency situations. Finally, we will briefly give an update on the advantages of lamotrigine in bipolar depression.